Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Abdelrahim, M.
Right arrow Articles by Safe, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Abdelrahim, M.
Right arrow Articles by Safe, S.
[Cancer Research 66, 2459-2467, February 15, 2006]
© 2006 American Association for Cancer Research


Endocrinology

3-Methylcholanthrene and Other Aryl Hydrocarbon Receptor Agonists Directly Activate Estrogen Receptor {alpha}

Maen Abdelrahim1, Eric Ariazi2, Kyounghyun Kim3, Shaheen Khan3, Rola Barhoumi4, Robert Burghardt4, Shengxi Liu1, Denise Hill1, Richard Finnell1, Bogdan Wlodarczyk1, V. Craig Jordan2 and Stephen Safe1,3

1 Institute of Biosciences and Technology, Texas A&M University Health Science Center, Houston, Texas; 2 Fox Chase Cancer Center, Philadelphia, Pennsylvania; and 3 Department of Veterinary Physiology and Pharmacology, and 4 Department of Veterinary Integrated Biosciences, Texas A&M University, College Station, Texas

Requests for reprints: Stephen Safe, Department of Veterinary Physiology and Pharmacology, Texas A&M University, 4466 TAMU, College Station, TX 77843-4466. Phone: 979-845-5988; Fax: 979-862-4929; E-mail: ssafe{at}cvm.tamu.edu.

3-Methylcholanthrene (3MC) is an aryl hydrocarbon receptor (AhR) agonist, and it has been reported that 3MC induces estrogenic activity through AhR-estrogen receptor {alpha} (ER{alpha}) interactions. In this study, we used 3MC and 3,3',4,4',5-pentachlorobiphenyl (PCB) as prototypical AhR ligands, and both compounds activated estrogen-responsive reporter genes/gene products (cathepsin D) in MCF-7 breast cancer cells. The estrogenic responses induced by these AhR ligands were inhibited by the antiestrogen ICI 182780 and by the transfection of a small inhibitory RNA for ER{alpha} but were not affected by the small inhibitory RNA for AhR. These results suggest that 3MC and PCB directly activate ER{alpha}, and this was confirmed in a competitive ER{alpha} binding assay and in a fluorescence resonance energy transfer experiment in which PCB and 3MC induced CFP-ER{alpha}/YFP-ER{alpha} interactions. In a chromatin immunoprecipitation assay, PCB and 3MC enhanced ER{alpha} (but not AhR) association with the estrogen-responsive region of the pS2 gene promoter. Moreover, in AhR knockout mice, 3MC increased uterine weights and induced expression of cyclin D1 mRNA levels. These results show that PCB and 3MC directly activate ER{alpha}-dependent transactivation and extend the number of ligands that activate both AhR and ER{alpha}. (Cancer Res 2006; 66(4): 2459-67)




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
E. Swedenborg, J. Ruegg, A. Hillenweck, S. Rehnmark, M. H. Faulds, D. Zalko, I. Pongratz, and K. Pettersson
3-Methylcholanthrene Displays Dual Effects on Estrogen Receptor (ER) {alpha} and ER{beta} Signaling in a Cell-Type Specific Fashion
Mol. Pharmacol., February 1, 2008; 73(2): 575 - 586.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
E. A. Ariazi, A. Leitao, T. I. Oprea, B. Chen, T. Louis, A. M. Bertucci, C. G.N. Sharma, S. D. Gill, H. R. Kim, H. A. Shupp, et al.
Exemestane's 17-hydroxylated metabolite exerts biological effects as an androgen
Mol. Cancer Ther., November 1, 2007; 6(11): 2817 - 2827.
[Abstract] [Full Text] [PDF]


Home page
Hum Exp ToxicolHome page
C. Bredhult, B.-M. Backlin, and M. Olovsson
Effects of chlorinated biphenyls and metabolites on human uterine myocyte proliferation
Human and Experimental Toxicology, October 1, 2007; 26(10): 801 - 809.
[Abstract] [PDF]


Home page
Hum Exp ToxicolHome page
N. Omori, H. Fukata, K. Sato, K. Yamazaki, K. Aida-Yasuoka, H. Takigami, M. Kuriyama, M. Ichinose, and C. Mori
Polychlorinated biphenyls alter the expression of endothelial nitric oxide synthase mRNA in human umbilical vein endothelial cells
Human and Experimental Toxicology, October 1, 2007; 26(10): 811 - 816.
[Abstract] [PDF]


Home page
Toxicol SciHome page
A. B. Okey
An Aryl Hydrocarbon Receptor Odyssey to the Shores of Toxicology: The Deichmann Lecture, International Congress of Toxicology-XI
Toxicol. Sci., July 1, 2007; 98(1): 5 - 38.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
E. G. van de Kerkhof, I. A. M. de Graaf, M. H. de Jager, and G. M. M. Groothuis
Induction of Phase I and II Drug Metabolism in Rat Small Intestine and Colon in Vitro
Drug Metab. Dispos., June 1, 2007; 35(6): 898 - 907.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
K. R. Barnett, D. Tomic, R. K. Gupta, K. P. Miller, S. Meachum, T. Paulose, and J. A. Flaws
The Aryl Hydrocarbon Receptor Affects Mouse Ovarian Follicle Growth via Mechanisms Involving Estradiol Regulation and Responsiveness
Biol Reprod, June 1, 2007; 76(6): 1062 - 1070.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2006 by the American Association for Cancer Research.